TRxADE HEALTH, Inc. (MEDS)
USD 7.59
(4.55%)
USD 7.59
(4.55%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.59 Million USD | -52.34% |
| 2022 | 5.45 Million USD | 14.86% |
| 2021 | 4.74 Million USD | -16.84% |
| 2020 | 5.7 Million USD | 17.18% |
| 2019 | 4.87 Million USD | 43.99% |
| 2018 | 3.38 Million USD | 15.4% |
| 2017 | 2.93 Million USD | 18.89% |
| 2016 | 2.46 Million USD | -19.54% |
| 2015 | 3.06 Million USD | 190.11% |
| 2014 | 1.05 Million USD | 8842.34% |
| 2013 | 11.81 Thousand USD | -89.84% |
| 2012 | 116.23 Thousand USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -8303.00 USD | 99.63% |
| 2024 Q2 | -703.00 USD | 91.53% |
| 2023 Q4 | -2.24 Million USD | -231.92% |
| 2023 FY | 2.59 Million USD | -52.34% |
| 2023 Q1 | 1.55 Million USD | 0.94% |
| 2023 Q2 | 1.64 Million USD | 5.63% |
| 2023 Q3 | 1.7 Million USD | 3.64% |
| 2022 FY | 5.45 Million USD | 14.86% |
| 2022 Q4 | 1.54 Million USD | 10.03% |
| 2022 Q2 | 1.17 Million USD | -12.34% |
| 2022 Q3 | 1.4 Million USD | 19.73% |
| 2022 Q1 | 1.33 Million USD | 7.7% |
| 2021 Q3 | 1.28 Million USD | 52.25% |
| 2021 FY | 4.74 Million USD | -16.84% |
| 2021 Q4 | 1.24 Million USD | -3.19% |
| 2021 Q1 | 1.38 Million USD | 939.21% |
| 2021 Q2 | 841.39 Thousand USD | -39.18% |
| 2020 Q4 | 133.11 Thousand USD | -93.1% |
| 2020 Q2 | 2 Million USD | 22.23% |
| 2020 Q1 | 1.64 Million USD | 31.18% |
| 2020 Q3 | 1.92 Million USD | -3.76% |
| 2020 FY | 5.7 Million USD | 17.18% |
| 2019 FY | 4.87 Million USD | 43.99% |
| 2019 Q4 | 1.25 Million USD | -4.59% |
| 2019 Q2 | 1.16 Million USD | 1.45% |
| 2019 Q1 | 1.14 Million USD | 35.38% |
| 2019 Q3 | 1.31 Million USD | 12.66% |
| 2018 Q2 | 837.68 Thousand USD | -1.79% |
| 2018 Q1 | 852.92 Thousand USD | 8.0% |
| 2018 Q4 | 846.99 Thousand USD | 0.22% |
| 2018 Q3 | 845.12 Thousand USD | 0.89% |
| 2018 FY | 3.38 Million USD | 15.4% |
| 2017 Q3 | 735.86 Thousand USD | 4.42% |
| 2017 FY | 2.93 Million USD | 18.89% |
| 2017 Q4 | 789.74 Thousand USD | 7.32% |
| 2017 Q2 | 704.72 Thousand USD | -5.53% |
| 2017 Q1 | 745.94 Thousand USD | 139.81% |
| 2016 Q2 | 649.1 Thousand USD | -21.9% |
| 2016 FY | 2.46 Million USD | -19.54% |
| 2016 Q3 | 572.6 Thousand USD | -11.78% |
| 2016 Q1 | 831.06 Thousand USD | -5.13% |
| 2016 Q4 | -1.87 Million USD | -427.26% |
| 2015 Q3 | 937.23 Thousand USD | 19.36% |
| 2015 FY | 3.06 Million USD | 190.11% |
| 2015 Q1 | 465.67 Thousand USD | 9.13% |
| 2015 Q2 | 785.19 Thousand USD | 68.62% |
| 2015 Q4 | 876.03 Thousand USD | -6.53% |
| 2014 Q2 | 236.53 Thousand USD | 142.83% |
| 2014 Q3 | 295.53 Thousand USD | 24.95% |
| 2014 Q1 | 97.4 Thousand USD | 290.74% |
| 2014 Q4 | 426.7 Thousand USD | 44.38% |
| 2014 FY | 1.05 Million USD | 8842.34% |
| 2013 FY | 11.81 Thousand USD | -89.84% |
| 2013 Q3 | -45.26 Thousand USD | -134.21% |
| 2013 Q1 | -24.19 Thousand USD | 0.0% |
| 2013 Q2 | 132.33 Thousand USD | 647.04% |
| 2013 Q4 | -51.06 Thousand USD | -12.82% |
| 2012 FY | 116.23 Thousand USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -105.67 Thousand USD | 2558.724% |
| BIMI International Medical Inc. | 1.94 Million USD | -33.247% |
| China Jo-Jo Drugstores, Inc. | 31.1 Million USD | 91.648% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 90.55 Million USD | 97.131% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 90.55 Million USD | 97.131% |
| Leafly Holdings, Inc. | 37.45 Million USD | 93.062% |
| Leafly Holdings, Inc. | 37.45 Million USD | 93.062% |
| LifeMD, Inc. | 126.01 Million USD | 97.938% |
| LifeMD, Inc. | 126.01 Million USD | 97.938% |
| PetMed Express, Inc. | 78.64 Million USD | 96.696% |
| Walgreens Boots Alliance, Inc. | 26.52 Billion USD | 99.99% |